149 related articles for article (PubMed ID: 9098692)
21. Competitive antagonism of the mouse 5-hydroxytryptamine3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor.
Coultrap SJ; Sun H; Tenner TE; Machu TK
J Pharmacol Exp Ther; 1999 Jul; 290(1):76-82. PubMed ID: 10381762
[TBL] [Abstract][Full Text] [Related]
22. Effect of cocaine on the 5-HT3 receptor-mediated ion current in Xenopus oocytes.
Fan P; Oz M; Zhang L; Weight FF
Brain Res; 1995 Mar; 673(2):181-4. PubMed ID: 7606430
[TBL] [Abstract][Full Text] [Related]
23. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.
van Hooft JA; Vijverberg HP
Br J Pharmacol; 1996 Mar; 117(5):839-46. PubMed ID: 8851499
[TBL] [Abstract][Full Text] [Related]
24. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
Yang KH; Galadari S; Isaev D; Petroianu G; Shippenberg TS; Oz M
J Pharmacol Exp Ther; 2010 May; 333(2):547-54. PubMed ID: 20160007
[TBL] [Abstract][Full Text] [Related]
25. Antagonism of 5-HT3 receptor mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine.
Peters JA; Malone HM; Lambert JJ
Neurosci Lett; 1990 Mar; 110(1-2):107-12. PubMed ID: 1691468
[TBL] [Abstract][Full Text] [Related]
26. Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.
Barann M; Schmidt K; Göthert M; Urban BW; Bönisch H
Br J Pharmacol; 2004 Jun; 142(3):501-8. PubMed ID: 15148263
[TBL] [Abstract][Full Text] [Related]
27. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
28. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
Hargreaves AC; Lummis SC; Taylor CW
Mol Pharmacol; 1994 Dec; 46(6):1120-8. PubMed ID: 7808432
[TBL] [Abstract][Full Text] [Related]
29. PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor.
Broad LM; Felthouse C; Zwart R; McPhie GI; Pearson KH; Craig PJ; Wallace L; Broadmore RJ; Boot JR; Keenan M; Baker SR; Sher E
Eur J Pharmacol; 2002 Oct; 452(2):137-44. PubMed ID: 12354563
[TBL] [Abstract][Full Text] [Related]
30. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Kooyman AR; van Hooft JA; Vanderheijden PM; Vijverberg HP
Br J Pharmacol; 1994 Jun; 112(2):541-6. PubMed ID: 8075873
[TBL] [Abstract][Full Text] [Related]
31. 5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells.
Kooyman AR; van Hooft JA; Vijverberg HP
Br J Pharmacol; 1993 Feb; 108(2):287-9. PubMed ID: 7680589
[TBL] [Abstract][Full Text] [Related]
32. Actions of general anaesthetics on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Jenkins A; Franks NP; Lieb WR
Br J Pharmacol; 1996 Apr; 117(7):1507-15. PubMed ID: 8730747
[TBL] [Abstract][Full Text] [Related]
33. Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes.
Gurley DA; Lanthorn TH
Neurosci Lett; 1998 May; 247(2-3):107-10. PubMed ID: 9655604
[TBL] [Abstract][Full Text] [Related]
34. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
35. An electrophysiological investigation of the properties of 5-HT3 receptors of rabbit nodose ganglion neurones in culture.
Peters JA; Malone HM; Lambert JJ
Br J Pharmacol; 1993 Oct; 110(2):665-76. PubMed ID: 7694755
[TBL] [Abstract][Full Text] [Related]
36. 5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.
Göthert M; Hamon M; Barann M; Bönisch H; Gozlan H; Laguzzi R; Metzenauer P; Nickel B; Szelenyi I
Br J Pharmacol; 1995 Jan; 114(2):269-74. PubMed ID: 7881726
[TBL] [Abstract][Full Text] [Related]
37. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
Mongeau R; De Montigny C; Blier P
Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of 5-HT3 receptor function by the activation of coexistent 5-HT2 receptors in trigeminal ganglion neurons of rats.
Hu WP; Guan BC; Ru LQ; Chen JG; Li ZW
Neuropharmacology; 2004 Nov; 47(6):833-40. PubMed ID: 15527817
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of 5-HT3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells.
Barann M; Bönisch H; Urban BW; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):145-52. PubMed ID: 9749998
[TBL] [Abstract][Full Text] [Related]
40. Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.
Morton RA; Baptista-Hon DT; Hales TG; Lovinger DM
Br J Pharmacol; 2015 Aug; 172(16):4066-77. PubMed ID: 25989383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
